Stockkar

Zydus Lifesciences Ltd. (ZYDUSLIFE) share price and key facts

Zydus Lifesciences Ltd. closed at ₹1,200.00 on the NSE on 20 Nov 2026. In the year to 20 Nov 2026, Zydus Lifesciences Ltd. shares rose 29.31%, from ₹928.00 on 20 Nov 2025. On 20 Nov 2026, Zydus Lifesciences Ltd. closed 10.28% above its 200-day EMA.

ZYDUSLIFE key facts

Key facts for Zydus Lifesciences Ltd., each with the date it is true for
FactValueAs of
Last close₹1,200.00NSE, 20 Nov 2026
52-week high₹1,266.604 Nov 2026
52-week low₹835.502 Apr 2026
Change, 1 week+0.85%since 13 Nov 2026
Change, 1 month+7.73%since 19 Oct 2026
Change, 3 months+8.33%since 20 Aug 2026
Change, 6 months+15.29%since 20 May 2026
Change, 1 year+29.31%since 20 Nov 2025
Market cap₹1.19 lakh crore20 Nov 2026
PE ratio (TTM)28.7820 Nov 2026
EPS (TTM)₹41.7020 Nov 2026
vs 20-day EMA0.62% above (EMA ₹1,192.61)20 Nov 2026
vs 50-day EMA2.38% above (EMA ₹1,172.06)20 Nov 2026
vs 200-day EMA10.28% above (EMA ₹1,088.18)20 Nov 2026
SectorHealthcare
IndustryPharmaceuticals & Drugs
NSE symbolZYDUSLIFE
BSE code532321
ISININE010B01027

Frequently asked questions

What is the share price of Zydus Lifesciences Ltd.?

Zydus Lifesciences Ltd. (ZYDUSLIFE) closed at ₹1,200.00 on the NSE on 20 Nov 2026. This page uses end-of-day closing prices and updates after each trading day.

What is the 52-week high and low of Zydus Lifesciences Ltd.?

In the 52 weeks to 20 Nov 2026, Zydus Lifesciences Ltd. reached a high of ₹1,266.60 on 4 Nov 2026 and a low of ₹835.50 on 2 Apr 2026.

What is the market cap of Zydus Lifesciences Ltd.?

Zydus Lifesciences Ltd. had a market capitalisation of ₹1.19 lakh crore on 20 Nov 2026.

What is the PE ratio of Zydus Lifesciences Ltd.?

On 20 Nov 2026, Zydus Lifesciences Ltd. had a trailing twelve-month PE ratio of 28.78, based on TTM earnings per share of ₹41.70.

How has the Zydus Lifesciences Ltd. share price changed over the past year?

Zydus Lifesciences Ltd. shares rose 29.31% in the year to 20 Nov 2026, from ₹928.00 on 20 Nov 2025 to ₹1,200.00. Over six months it rose 15.29%; over one month it rose 7.73%.

Is Zydus Lifesciences Ltd. trading above its 200-day EMA?

Yes. On 20 Nov 2026, Zydus Lifesciences Ltd. closed at ₹1,200.00, 10.28% above its 200-day exponential moving average of ₹1,088.18. It was 2.38% above its 50-day EMA. Stockkar's EMAs are adjusted for splits and bonuses but not for dividends, so they can differ slightly from other charts.

Which sector and industry is Zydus Lifesciences Ltd. in?

Zydus Lifesciences Ltd. is classified in the Healthcare sector and the Pharmaceuticals & Drugs industry. Other companies in the same industry include Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd. and Torrent Pharmaceuticals Ltd.

What is the stock symbol of Zydus Lifesciences Ltd.?

Zydus Lifesciences Ltd. trades on the NSE as ZYDUSLIFE and on the BSE under code 532321. Its ISIN is INE010B01027.

Facts as of 20 Nov 2026, from Stockkar's end-of-day snapshot. Each value shows the date it is true for.

Prices are end-of-day closing prices from the exchange where the stock traded on more days in the past year. Changes compare closing prices. EMAs are adjusted for splits and bonuses, not for dividends.

Stockkar is not registered with SEBI as an investment adviser or research analyst. This page describes market data and is not investment advice.